Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Sabine D. Brookman May"'
Autor:
Moritz von B?ren, Christian W?lfing, Daniel Schlager, Max Michael Tr?ger, Marcel Daoud, Florian Schr?der, Sabine D. Brookman-May, Christian Gratzke, Johannes von B?ren
Publikováno v:
Telemedicine Reports, Vol 4, Iss 1, Pp 118-125 (2023)
Background: Direct-to-consumer (DTC) online prescription platforms (OPP) for sexual health represent a potential paradigm shift in the diagnosis and treatment for sexual dysfunctions in the way men seek care. Knowledge of patients' risk profile using
Externí odkaz:
https://doaj.org/article/6a898a98ee3d4df88065ee73505dae1b
Autor:
Byung Ha Chung, Jian Huang, Hiroji Uemura, Young Deuk Choi, Zhang-Qun Ye, Hiroyoshi Suzuki, Taek Won Kang, Da-Lin He, Jae Young Joung, Sabine D Brookman-May, Sharon McCarthy, Amitabha Bhaumik, Anildeep Singh, Suneel Mundle, Simon Chowdhury, Neeraj Agarwal, Ding-Wei Ye, Kim N Chi, Hirotsugu Uemura
Publikováno v:
Asian Journal of Andrology, Vol 25, Iss 6, Pp 653-661 (2023)
The final analysis of the phase 3 Targeted Investigational Treatment Analysis of Novel Anti-androgen (TITAN) trial showed improvement in overall survival (OS) and other efficacy endpoints with apalutamide plus androgen deprivation therapy (ADT) versu
Externí odkaz:
https://doaj.org/article/c78d4747b1574342b443336c6734afee
Autor:
Steffen Lebentrau, Gamal Anton Wakileh, Martin Schostak, Hans-Peter Schmid, Rodrigo Suarez-Ibarrola, Axel S. Merseburger, Georg C. Hutterer, Ulrike H. Necknig, Michael Rink, Martin Bögemann, Luis Alex Kluth, Armin Pycha, Maximilian Burger, Sabine D. Brookman-May, Johannes Bründl, Matthias May
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundPenile cancer represents a rare malignant disease, whereby a small caseload is associated with the risk of inadequate treatment expertise. Thus, we hypothesized that strict guideline adherence might be considered a potential surrogate for t
Externí odkaz:
https://doaj.org/article/c1376d782de048189d86ed4a5b3c2f01
Autor:
Moritz von Büren, Christian Wülfing, Sabine D. Brookman-May, Christian Gratzke, Johannes von Büren
Publikováno v:
European Urology Focus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a809d4384ff6449e41a5a4973298d2cd
https://doi.org/10.1016/j.euf.2023.03.026
https://doi.org/10.1016/j.euf.2023.03.026
Autor:
Finn Abeck, Inga Hansen, Isabell Wiesenhütter, Sabine D. Brookman-May, Kariem Sharaf, Julian Kött, Mattis Bertlich, Stefan W. Schneider, Johannes von Büren
Publikováno v:
Telemedicine and e-Health.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a7566b09755c41c4542e2295b78f34f
https://doi.org/10.1089/tmj.2022.0290
https://doi.org/10.1089/tmj.2022.0290
Autor:
Nina Wagener, Dominic Edelmann, Axel Benner, Richard Zigeuner, Hendrik Borgmann, Ingmar Wolff, Laura M Krabbe, Mireia Musquera, Paolo Dell'Oglio, Umberto Capitanio, Tobias Klatte, Luca Cindolo, Matthias May, Sabine D Brookman-May, European Association of Urology (EAU) Young Academic Urologists (YAU) Kidney Cancer Group
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0184173 (2017)
Renal cell carcinoma (RCC) comprises a heterogenous group of tumors. Traditionally, papillary RCC (pRCC) is associated with a favorable outcome compared to clear cell RCC (ccRCC), while other series report equivalent or worse prognosis. In this paper
Externí odkaz:
https://doaj.org/article/5784d460830f49f7b457e739b82c5081
Autor:
Adam S. Kibel, Martin Gleave, Sabine D. Brookman-May, Won Kim, Christopher P. Evans, Eleni Efstathiou, Philip W. Kantoff, Ashley Ross, Neal D. Shore, Alberto Briganti, Boris A. Hadaschik, Axel Heidenreich, Oliver Brendan Rooney, Shaozhou Ken Tian, Lisa Wetherhold, Weichun Xu, J. Kellogg Parsons, Kesav Yeruva, Mary-Ellen Taplin
TPS285 Background: In pts with localized high-risk PC, disease recurrence rate following RP is ̃50% (Kane et al. J Urol. 2007). Treatment (tx) with androgen blockade before RP can reduce tumor burden post RP (Taplin et al. J Clin Oncol. 2014; McKay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7471f5ec855334535368386ed3ab903
Publikováno v:
Scandinavian Journal of Urology. 56:334-335
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec4d23dcead8316aac23d9ddd0f44dd1
https://doi.org/10.1080/21681805.2022.2107068
https://doi.org/10.1080/21681805.2022.2107068
Autor:
YaoYao Pollock, Matthew R. Smith, Fred Saad, Simon Chowdhury, Stéphane Oudard, Boris Hadaschik, David Olmos, Ji Youl Lee, Hiroji Uemura, Amitabha Bhaumik, Anil Londhe, Brendan Rooney, Sabine D. Brookman-May, Peter De Porre, Suneel D. Mundle, Eric J. Small
Publikováno v:
Prostate cancer and prostatic diseases.
Background: The phase III SPARTAN study demonstrated that apalutamide significantly improves metastasis-free survival and overall survival vs. placebo in patients with non-metastatic castration-resistant prostate cancer (nmCRPC). However, patients re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54149789655884f2f8d8b035d4b1aa59
https://pubmed.ncbi.nlm.nih.gov/36209239
https://pubmed.ncbi.nlm.nih.gov/36209239
Autor:
Neeraj Agarwal, Justin Lucas, Clemente Aguilar-Bonavides, Shibu Thomas, Michael Gormley, Simon Chowdhury, Axel S. Merseburger, Anders Bjartell, Hirotsugu Uemura, Mustafa Özgüroğlu, Sharon McCarthy, Sabine D. Brookman-May, Florence Lefresne, Suneel Mundle, Kim N. Chi
Publikováno v:
Journal of Clinical Oncology. 40:5066-5066
5066 Background: TITAN, a phase 3 PBO-controlled study in patients (pts) with mCSPC, showed APA + ADT improved radiographic progression-free survival and OS vs PBO + ADT. In this exploratory analysis, we report the relationships between biomarkers an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::239c313c8a96e92078558ab5c2bd2daf
https://doi.org/10.1200/jco.2022.40.16_suppl.5066
https://doi.org/10.1200/jco.2022.40.16_suppl.5066